Enrichment Strategies for Rare Mutations
Enrichment Strategies for Rare Mutations Implementing Enrichment Strategies for Rare Mutations in Oncology Trials Introduction to Enrichment Strategies Enrichment strategies in oncology clinical trials refer to the deliberate selection of a patient population most likely to benefit from a targeted therapy based on biomarker status. This is particularly critical for rare mutations, where the prevalence…